Echo Therapeutics (ECTE) Posts Wider than Expected Q1 Loss of 8c/Share
Tweet Send to a FriendGet Alerts ECTE Hot Sheet
Price: $2.62 -4.38%
EPS Growth %: -62.5%
Financial Fact:
Total operating expenses: 5.52M
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: -62.5%
Financial Fact:
Total operating expenses: 5.52M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade ECTE Now!
Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $30.93 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- UPDATE: Citi Raises PT on Micron Technology (MU) to $19
- Red Hat, Inc. (RHT) Tops Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
